Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of KMG Chemicals, Inc. (KMG) on Behalf of Stockholders and Encourages Investors to Contact the Firm

New York, New York, UNITED STATES

NEW YORK, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against KMG Chemicals, Inc. (NYSE: KMG) on behalf of stockholders concerning the proposed acquisition of the company by Cabot Microelectronics Corporation.

Pursuant to the proposed transaction, announced on August 15, 2018 and valued at approximately $1.6 billion, KMG stockholders will receive $55.65 per share in cash and 0.20 shares of Cabot Microelectronics for their KMG common stock.  Our investigation concerns whether KMG’s board of directors failed to adequately shop the company and obtain the best possible price for its stockholders before entering into a definitive agreement with Cabot Microelectronics.

If you own KMG shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at, or telephone at (212) 308-1869, or by filling out this contact form.  There is no cost or obligation to you.

Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation.  For additional information concerning our investigation of KMG Chemicals, Inc. please go to  For additional information about Bragar Eagel & Squire, P.C. please go to

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 308-1869